Dysphagia in Rheumatoid Arthritis

Last updated: June 6, 2026
Sponsor: Tanta University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Rheumatoid Arthritis

Treatment

flexible fiberoptic pharyngolaryngoscopy

Clinical Study ID

NCT07401732
36264PR772/7/24
  • Ages > 18
  • All Genders

Study Summary

The primary goal of this cross-sectional study is to assess risk factors/predictors for dysphagia severity in RA.

The secondary goals include demonstrating whether flexible fiberoptic pharyngolaryngoscopy can diagnose joint-affection-induced dysphagia in patients with rheumatoid arthritis (RA) and whether both oropharyngeal and esophageal dysphagia are present among these patients.

The main questions it aims to answer are

  • What are the predictors that are associated with dysphagia severity via flexible fiberoptic pharyngolaryngoscopy in rheumatoid arthritis patients?

  • Whether flexible fiberoptic pharyngolaryngoscopy can diagnose joint-affection-induced dysphagia in patients with RA?

  • Whether both oropharyngeal and esophageal dysphagia are present in patients with RA?

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with Rheumatoid arthritis defined by the American College ofRheumatology/European League Against Rheumatism collaborative initiative (ACR/EULAR) 2010 classification criteria.

  • Patients aged above 18 years old, well-orientated, and cooperative.

Exclusion

Exclusion Criteria:

  • concomitant cancer diagnosis, pregnancy.

  • jaw-related traumas, teeth and gum diseases.

  • other rheumatologic conditions

  • other comorbidities.

  • other causes of TMJ arthritis, patients with TMJ, palatal or tongue congenitalabnormalities, and patients who underwent TMJ injections in the last six months.

  • Patients with any language disorders or intellectually handicapped (as certainquestions depend on the patient's ability to comprehend and express their emotionsregarding their issue) and patients with anatomical anomalies impeding thefunctionality of flexible nasofibroscopy.

  • Any apparent causes of dysphagia other than RA.

Study Design

Total Participants: 137
Treatment Group(s): 1
Primary Treatment: flexible fiberoptic pharyngolaryngoscopy
Phase:
Study Start date:
February 07, 2026
Estimated Completion Date:
July 31, 2026

Study Description

This cross-sectional study will comprise RA patients during their visits to inpatient and outpatient clinics. The inclusion criterion is patients with RA defined by the American College of Rheumatology/European League Against Rheumatism collaborative initiative (ACR/EULAR) 2010 classification criteria. Patients aged above 18 years old, well-orientated, and cooperative.

Connect with a study center

  • Faculty of medicine, Tanta University

    Tanta, Elgharbia 31151
    Egypt

    Active - Recruiting

  • Rheumatology, rehabilitation, and physical medicine department Faculty of medicine, Tanta University

    Tanta, Elgharbia 31151
    Egypt

    Active - Recruiting

  • Faculty of medicine, Tanta University

    Tanta 347497, Elgharbia 31151
    Egypt

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.